Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

NCT01394029 · clinicaltrials.gov ↗

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Transfusional Hemosiderosis

Interventions

DRUG: deferasirox

Sponsor

Novartis Pharmaceuticals